This cocktail was used to stimulate CLL cells harvested from a cohort of patients with different biological characteristics (IGHV UM/M, ZAP70+/− and CD38+/−) and control B cells from healthy donors. The gene discussed is ZAP70; the disease is B-cell chronic lymphocytic leukemia.